There were 825 press releases posted in the last 24 hours and 183,867 in the last 365 days.

Speakers Confirmed for Medical Affairs Professional Society (MAPS) Global Annual Meeting 2022

Medical Affairs Professional Society (MAPS) Global Annual Meeting 2022

Medical Affairs Professional Society (MAPS) Global Annual Meeting 2022

500+ Medical Affairs professionals will convene in New Orleans March 20-23, 2022 for the largest annual gathering FOR Medical Affairs, BY Medical Affairs

From Vision to Action-Medical Affairs’ Time to Lead is Now”
GOLDEN, COLO, UNITED STATES, October 21, 2021 / -- The Medical Affairs Professional Society (MAPS) is excited to announce speakers for the MAPS Global Annual Meeting, taking place in New Orleans, Louisiana March 20-23, 2022. The event is the largest annual gathering of Medical Affairs professionals, with over 500+ Medical Affairs professionals from around the world convening for this one-of-a-kind event developed for Medical Affairs, by Medical Affairs. Early Bird registration for individuals and teams is open through November 19, 2021. Now is the defining moment for Medical Affairs as we fully realize our place as a strategic pillar in the biopharmaceutical and MedTech industries. The theme of the 2022 Global Annual Meeting, "From Vision to Action-Medical Affairs’ Time to Lead is Now," reflects the pivotal moment in which Medical Affairs professionals find themselves post-pandemic.

Confirmed speakers include the following. See more faculty and take advantage of early bird registration.

April Adams, PharmD, Senior Director for Field Medical Affairs, Bristol Myers Squibb

Maarten Beekman, MD, Medical Director, Internal Consultant to International Medical Respiratory & Immunology, AstraZeneca

Kathy Belk, Vice President, Real-World Evidence and Data Analytics, Healthcare Consultancy Group

Sonal Bhatia, MD, Chief Medical Officer, Rare Disease, Pfizer

Chris Blanchette, PhD, MBA, VP, and Head, Clinical Development and Outcomes Research, Novo Nordisk

Leigh Boehmer, MD, Chief Medical Officer, Association of Community Cancer Centers

Sarah Burns, Data Visualization Director, Global Scientific Communications, Eli Lilly & Company

Steve Casey, Managing Partner, OmniHealthcare Communications LLC

Laura Clark, Senior Research Scientist, Real-World Evidence and Data Analytics, Healthcare Consultancy Group

Deborah Crawford, MSL Team & Therapeutic Lead, Teva Pharmaceuticals

Omar Dabbous, MD, MPH, VP, Global HEOR and Real World Evidence, AveXis, Inc., a Novartis Company

Alex Derchak, PhD, Executive Director, External Engagement, Amgen

Ivan Desviat, MBA, CHCP, Director, Medical Education Excellence, AbbVie

Mike Devoy, MD, Chief Medical Officer, Executive VP, Medical Affairs & Pharmacovigilance, Bayer

Luca Dezzani, MD, Franchise Head, US Immuno-oncology Medical Affairs, AstraZeneca

Aalap Dighe, Associate Partner, McKinsey and Company

Elvira Dsouza, President, Cactus Life Sciences

Danie du Plessis, MD, MBA, Executive VP, Medical Affairs, Kyowa Kirin International

Catherine Duehren, DNP, RN, Director, Clinical Solutions, Medical Affairs and Informatics, Hillrom

Sissy Easo-Joseph, MS, Ph.D, Director, Scientific Communications, Migraine and Headache, Teva Pharmaceuticals

Laura Engles-Horton, PharmD, Director, Medical Learning and Development, Bayer

Matthew Frankel, MD, Vice President, Clinical Development and Medical Affairs, Specialty Care, Boehringer Ingelheim

Sarah Funderburk, PhD, CMPP, SVP, Senior Medical Strategy Director, Caudex, a McCann Health Company

Wendy Fraser, Executive Director, Field Medical Center of Excellence & Scientific Training, Merck & Co.

Alba Garcia Estella, Associate Partner, McKinsey and Company

Meg Glancey, MSPH, Clinical Advisory Manager, Marimac Insight

Eleonora Goldberg, Executive Director, Global Field Medical Excellence, Amgen

Heather Goolsby, PhD, Director, Medical Learning and Development, Bayer

Gokul Gopalan, VP, Global Medical Affairs, Vertex Pharmaceuticals

Robert Groebel, VP Global Medical Strategy, Monocl

Rebecca Harmon, PharmD, MBA, Senior Advisor/COO, Diabetes Development, Eli Lilly and Company

Rachel Hatfield, Ph.D, Managing Partner, MEDiSTRAVA Consulting

Ross Heritage, Chief Technology Officer, Pharmaspectra

Donna Holder, Senior Director, Global MSL Excellence

Tony Hooper, Independent Director

Emily Howmann, Ph.D, Senior Medical Strategy Lead, Envision Pharma

Barb Jones, PhD, SVP, Scientific Operations and Regulatory Affairs, Vyant Bio

Marieke Jonkman, PharmD, PCC, Medical Affairs Executive Coach, The Medical Affairs Leadership Institute

Deirdre Jordan, MSc, Global Medical Affairs Excellence Lead, Sandoz

Renu Juneja, PhD, Head, Scientific Evidence & Communications, Oncology US Medical Affairs, Janssen

Aaron Kamauu, Managing Director, HCG Luminary Expert, Ikaika Health

Wendy Kampman, Global Medical Franchise Lead, General Medicine & Infectious Disease, Regeneron

David Kelaher, Chief Medical Officer, Pharmaspectra

Jessica Klein, Director, Global Rare Diseases, Ipsen

Simon Kyaga, MD, PhD, Global Medical Director, Alzheimer's Disease, for Europe Canada and Partner Markets (ECP), Biogen

Suzanna Lawrence, Global Health Medical, Amplity Health

Matt Lewis, Global Chief Medical Analytics and Innovation Officer, MEDiSTRAVA

Grace Macalino, Ph.D, CEO and Professional Practices Managing Director, Marimac Insights

Lizandra Marcondes, Head of Medical Affairs Averitas, Grünenthal Group

Canter Martin, Executive Vice President & Managing Director, Healthcare Consultancy Group

Pamela Mason, BS, CHCP, FACEHP, ATSF, Senior Director, Medical Education Grants Office, AstraZeneca

Yasamin Mir-Shekari, Global Lead, Medical Strategy, Envision Pharma Group

Mark Monane, MD, MBA, ACC, Chief Medical Officer, Monane Group Clinical Consulting

Lori Mouser, Global Head, Medical Customer Engagement, Roche

Jean-Jacques Murama, BSC, MBA, Medical Education Affairs Education, Launch and TL Engagement Global Medical Affairs Office, Eli Lilly and Company

Jameel Nazir, PhD, Global Head, HEOR, Sobi

Ali Nourbaksh, Sr. Director of Medical Affairs, Otsuka

Paul O'Grady, PhD, Global Oncology Scientific Communications and Strategy Head, GSK

Lucy Perez, Senior Partner, McKinsey and Company

Frank Pompilio, VP, Medical Affairs, Arcutis Biotherapeutics

Olga Salvidio, Director, Global Medical Education & Academic Organization Relations, Merck

Jessica Santos, Global Compliance and Quality Director, Kantar Health

Monicca Shanthanelson, Ph.D, CMPP, VP Global Medical Consulting, Veeva Systems

Marija Simin Geertsen, MD, PhD, VP, Medical Affairs, Lundbeck

Surinder Singh, Suringer Singh, Vice President, Head of U.S. Medical Affairs, Otsuka Pharmaceutical Development & Commercialization, Inc.

Cassie Stox, Senior Director, Media Strategy & Audience Insights, Medthink

Richard Swank, US Medical Capabilities Lead, Amgen

Marco Taglietti, MD, President and CEO, SYNEXIS

Cameron Tew, VP of Account Management, MedEvoke

Mondher Toumi, Professor of Public Health, Aix-Marseille University; President & CEO, CreativCeutical

Russell Traynor, Head of Product Strategy & Management, Envision Pharma Group

Carlos Urrea, MD, MPH, VP, Medical Affairs and Informatics, Hillrom

Anna Walz, Founder & CEO Emeritus, MedEvoke & Senior Strategic Advisor, MEDiSTRAVA

Johnathan Wert, MD, Senior Vice President, Medical Strategy, Healthcare Consultancy Group

Ann Westra, Senior Knowledge Expert, McKinsey and Company

About MAPS
MAPS is the premier nonprofit global Medical Affairs organization for Medical Affairs professionals by Medical Affairs professionals across all different levels of experience/specialty to engage, empower, and educate. Together with more than 6,300 Medical Affairs members from more than 220 companies globally, MAPS is transforming the Medical Affairs profession to increase its value to patients, HCPs, and other decision-makers.

Garth Sundem
Medical Affairs Professional Society (MAPS)
+1 805-559-2023
email us here
Visit us on social media: